Cardinal Health (CAH) is back on investors’ radar after fresh company data highlighted revenue of about US$234.3b and net ...

Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer discussed, along with market shortages. Mentioning that they like the company, a caller asked for Cramer’s take on it, and he replied: ...

Investor confidence is elevated as Cardinal Health prepares to disclose its quarterly financial performance this week. The healthcare services and distribution giant is scheduled to release results ...

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

New NAHR Fellow and retiring CHRO Ola Snow of Cardinal Health says investment in culture has been critical to the ...

Cardinal Health has updated its financial outlook for fiscal year 2026 non-GAAP diluted earnings per share (EPS) to at least ...

Cardinal Health stock reached an all-time high of $215.54, marking a significant milestone for the $50.7 billion healthcare company. Over the past year, Cardinal Health has experienced a remarkable 66 ...

Cardinal Health (CAH) upgraded to Buy after a 100%+ run—see FY26 guidance, acquisitions, and nuclear medicine catalysts, plus ...

Dallas-based GI Alliance has entered a definitive agreement with Dublin, Ohio-based pharmaceutical distributor and healthcare services company Cardinal Health in which Cardinal will acquire a majority ...

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's ...

Use of Non-GAAP MeasuresThis earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In addition to analyzing ...